top of page
Search
Chang-Han Lee
Dec 22, 20232 min read
Safety and efficacy of a novel anti-CD19 chimeric antigen receptor T cell product targeting a membrane-proximal domain of CD19 with fast on- and off-rates against non-Hodgkin lymphoma
https://link.springer.com/article/10.1186/s12943-023-01886-9 Background Commercial anti-CD19 chimeric antigen receptor T-cell therapies...
4
Chang-Han Lee
Nov 28, 20231 min read
Targeting of intracellular oncoproteins with peptide-centric CARs
Nature (2023). https://doi.org/10.1038/s41586-023-06706-0 https://www.nature.com/articles/s41586-023-06706-0 The majority of oncogenic...
5
Chang-Han Lee
Nov 28, 20231 min read
Harnessing CD3 diversity to optimize CAR T cells
Nat Immunol (2023). https://doi.org/10.1038/s41590-023-01658-z https://www.nature.com/articles/s41590-023-01658-z Current US Food and...
3
Chang-Han Lee
Nov 28, 20231 min read
Functional diversification and dynamics of CAR-T cells in patients with B-ALL
Cell reports Volume 42, Issue 10, 31 October 2023, 113263 https://pubmed.ncbi.nlm.nih.gov/37851569/ ​ Highlights · Longitudinal...
1
bottom of page